PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 23248402-0 2012 Detection of interleukin -1beta from isolated human lymphocyte in response to lipopolysaccharide and lipoteichoic acid. lipoteichoic acid 101-118 interleukin 1 beta Homo sapiens 13-31 24117794-0 2013 Myricetin suppresses lipoteichoic acid-induced interleukin-1beta and cyclooxygenase-2 expression in human gingival fibroblasts. lipoteichoic acid 21-38 interleukin 1 beta Homo sapiens 47-64 23382974-3 2013 Adenosine triphosphate (ATP) and the TLR2 ligand lipoteichoic acid (LTA) selectively and synergistically induced expression of IL-23 and IL-1beta from cultured monocytes as determined by ELISA assays. lipoteichoic acid 49-66 interleukin 1 beta Homo sapiens 137-145 23382974-3 2013 Adenosine triphosphate (ATP) and the TLR2 ligand lipoteichoic acid (LTA) selectively and synergistically induced expression of IL-23 and IL-1beta from cultured monocytes as determined by ELISA assays. lipoteichoic acid 68-71 interleukin 1 beta Homo sapiens 137-145 24894535-9 2014 Caspase-1-dependent IL-1beta secretion was impaired in monocytes from patients with AD compared to patients with psoriasis and healthy controls by alpha-toxin stimulation following priming with lipoteichoic acid. lipoteichoic acid 194-211 interleukin 1 beta Homo sapiens 20-28 25002964-6 2014 RESULTS: Probiotic supplementation was associated with decreased LTA (lipoteichoic acid) induced CCL4, CXCL8, IL-1beta and IL-6 responses at 12 months and decreased CCL4 and IL-1beta secretion at 24 months. lipoteichoic acid 70-87 interleukin 1 beta Homo sapiens 110-118 23248402-1 2012 AIM: To detect the interleukin -1beta levels from single and pooled isolated human lymphocytes in response to lipolysaccharide and lipoteichoic acid. lipoteichoic acid 131-148 interleukin 1 beta Homo sapiens 19-37 23006534-9 2012 RESULTS: Incubation with LPS, LTA or TCS significantly increased TNF-alpha, IL-1beta, IL-6, IL-8, IFN-gamma and IL-2 in comparison to incubation with RPMI alone. lipoteichoic acid 30-33 interleukin 1 beta Homo sapiens 76-84 15458513-5 2004 RESULTS: Increased interleukin 1beta (IL1beta) and IL8 release by in vitro cultured normal PBMC was observed after stimulation with LTA at concentrations > or =5 microg/mL; these levels were lower than for lipopolysaccharide (LPS)-stimulated cells and LTA antagonized LPS-induced cytokine release by normal PBMC. lipoteichoic acid 132-135 interleukin 1 beta Homo sapiens 19-36 15458513-5 2004 RESULTS: Increased interleukin 1beta (IL1beta) and IL8 release by in vitro cultured normal PBMC was observed after stimulation with LTA at concentrations > or =5 microg/mL; these levels were lower than for lipopolysaccharide (LPS)-stimulated cells and LTA antagonized LPS-induced cytokine release by normal PBMC. lipoteichoic acid 132-135 interleukin 1 beta Homo sapiens 38-45 1937822-1 1991 Lipoteichoic acids (LTAs) isolated from bacterial species, including Staphylococcus aureus, Streptococcus pyogenes A, Enterococcus faecalis, Streptococcus pneumoniae, and Listeria monocytogenes, were tested for their ability to stimulate the production of interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor alpha in cultured human monocytes. lipoteichoic acid 0-18 interleukin 1 beta Homo sapiens 276-285 22389976-0 2012 [Study on the expression of Toll like receptor 2 and interleukin-1 beta induced by Enterococcus faecalis lipoteichoic acid on human periodontal ligament cells]. lipoteichoic acid 105-122 interleukin 1 beta Homo sapiens 53-71 16343789-6 2006 Lipoteichoic acid-activated glial cells produced nitric oxide and pro-inflammatory cytokines (tumor necrosis factor-alpha and interleukin-1beta) that contributed to lipoteichoic acid-induced blood-brain barrier disruption, since the direct treatment of the endothelial monolayer with tumor necrosis factor-alpha or interleukin-1beta increased blood-brain barrier permeability, whereas the pre-treatment of lipoteichoic acid-activated glial cells with antibodies against these two cytokines blocked lipoteichoic acid effects. lipoteichoic acid 0-17 interleukin 1 beta Homo sapiens 126-143 16343789-6 2006 Lipoteichoic acid-activated glial cells produced nitric oxide and pro-inflammatory cytokines (tumor necrosis factor-alpha and interleukin-1beta) that contributed to lipoteichoic acid-induced blood-brain barrier disruption, since the direct treatment of the endothelial monolayer with tumor necrosis factor-alpha or interleukin-1beta increased blood-brain barrier permeability, whereas the pre-treatment of lipoteichoic acid-activated glial cells with antibodies against these two cytokines blocked lipoteichoic acid effects. lipoteichoic acid 0-17 interleukin 1 beta Homo sapiens 315-332 16343789-6 2006 Lipoteichoic acid-activated glial cells produced nitric oxide and pro-inflammatory cytokines (tumor necrosis factor-alpha and interleukin-1beta) that contributed to lipoteichoic acid-induced blood-brain barrier disruption, since the direct treatment of the endothelial monolayer with tumor necrosis factor-alpha or interleukin-1beta increased blood-brain barrier permeability, whereas the pre-treatment of lipoteichoic acid-activated glial cells with antibodies against these two cytokines blocked lipoteichoic acid effects. lipoteichoic acid 165-182 interleukin 1 beta Homo sapiens 126-143 16343789-6 2006 Lipoteichoic acid-activated glial cells produced nitric oxide and pro-inflammatory cytokines (tumor necrosis factor-alpha and interleukin-1beta) that contributed to lipoteichoic acid-induced blood-brain barrier disruption, since the direct treatment of the endothelial monolayer with tumor necrosis factor-alpha or interleukin-1beta increased blood-brain barrier permeability, whereas the pre-treatment of lipoteichoic acid-activated glial cells with antibodies against these two cytokines blocked lipoteichoic acid effects. lipoteichoic acid 165-182 interleukin 1 beta Homo sapiens 315-332 12691617-3 2003 LPS-TLR4-adapted human THP-1 promonocytic cells cross-adapt to lipoteichoic acid (LTA)-TLR2-induced IL-1beta/TNF-alpha production, suggesting disruption of a common intracellular signaling event(s). lipoteichoic acid 63-80 interleukin 1 beta Homo sapiens 100-108 12691617-3 2003 LPS-TLR4-adapted human THP-1 promonocytic cells cross-adapt to lipoteichoic acid (LTA)-TLR2-induced IL-1beta/TNF-alpha production, suggesting disruption of a common intracellular signaling event(s). lipoteichoic acid 82-85 interleukin 1 beta Homo sapiens 100-108